UTPγS trisodium salt
Cat. No. 3279
Chemical Name: Uridine-5'-(γ-thio)-triphosphate trisodium salt
Biological ActivitySelective P2Y2 and P2Y4 receptor agonist. Enzymatically stable.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Safety Data Sheet
Malmsjo et al (2003) The stable pyrimidines UDPβS and UTPγS discriminate between contractile cerebrovascular P2 receptors. Eur.J.Pharmacol. 458 305. PMID: 12504787.
Malmsjo et al (2000) The stable pyrimidines UDPβS and UTPγS discriminate between the P2 receptors that mediate vascular contraction and relaxation of the rat mesenteric artery. Br.J.Pharmacol. 131 51. PMID: 10960068.
Lazarowski et al (1996) Enzymatic synthesis of UTPγS, a potent hydrolysis resistant agonist of P2U-purinoceptors. Br.J.Pharmacol. 117 203. PMID: 8825364.
If you know of a relevant reference for this product please let us know.
Citations are publications that use Tocris products. Selected citations for UTPγS trisodium salt include:
Gault et al (2014) Osmotic surveillance mediates rapid wound closure through nucleotide release. J Cell Biol 207 767. PMID: 25533845.
Do you know of a great paper that uses UTPγS trisodium salt from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: UTPgS trisodium salt, supplier, Selective, P2Y2/4, agonists, Receptors, Purinergic, purinoceptors, UTPgammaS, UTPγS, trisodium, salt, Tocris Bioscience, Purinergic (P2Y) Receptor Agonist products
Find multiple products by catalog number
New Products in this Area
FFA2 antagonist/inverse agonistOleanolic acid
Selective GPBA receptor (TGR5) partial agonistPPTN hydrochloride
High affinity and selective P2Y14 antagonistItraconazole
SMO antagonist; acts at different binding site to cyclopamine (Cat No. 1623)SAR 216471 hydrochloride
Potent P2Y12 antagonist; orally availableA 971432
Potent and selective S1P5 agonistGLPG 0974
Potent FFA2 antagonistOgerin
Selective positive allosteric modulator at GPR68BGC 20-1531 hydrochloride
High affinity and selective EP4 antagonistMontelukast sodium
CysLT1 and GPR17 antagonist
November 12 - 16, 2016
San Diego, CA, USA